Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Methylxanthine [EPC]
Theophylline Anhydrous is a methylxanthine bronchodilator used to treat chronic respiratory conditions such as asthma and COPD. It works by relaxing airway smooth muscle and improving diaphragm contractility.
Name
Theophylline Anhydrous
Raw Name
THEOPHYLLINE ANHYDROUS
Category
Methylxanthine [EPC]
Drug Count
3
Variant Count
49
Last Verified
February 17, 2026
RxCUI
198264, 313272, 313310, 701712, 844590, 844591, 844813, 844829, 313291, 348472, 314241, 317769, 237178, 346574, 313306
UNII
0I55128JYK
About Theophylline Anhydrous
Theophylline Anhydrous is a methylxanthine bronchodilator used to treat chronic respiratory conditions such as asthma and COPD. It works by relaxing airway smooth muscle and improving diaphragm contractility.
Detailed information about Theophylline Anhydrous
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Theophylline Anhydrous.
Theophylline Anhydrous is a potent pharmacological agent belonging to the methylxanthine [EPC] class of medications. Historically, it has served as a cornerstone in the long-term management of chronic obstructive pulmonary disease (COPD) and persistent asthma. Chemically related to caffeine and theobromine, theophylline is a naturally occurring alkaloid that was first extracted from tea leaves in the late 19th century and subsequently synthesized for medical use. The 'anhydrous' designation indicates that the drug molecule does not contain water of crystallization, ensuring a standardized potency by weight compared to hydrous forms.
Healthcare providers typically prescribe Theophylline Anhydrous when other first-line therapies, such as inhaled corticosteroids or long-acting beta-agonists, are insufficient to control symptoms. It is classified as a bronchodilator (a medication that opens the airways) and also possesses mild anti-inflammatory properties. The FDA first approved various formulations of theophylline in the mid-20th century, and while newer inhaler-based therapies have shifted its role to a second- or third-line treatment, it remains an essential tool for patients with refractory (difficult to treat) respiratory disease.
The mechanism of action for Theophylline Anhydrous is multi-faceted and involves several distinct cellular pathways. At the most fundamental level, it acts as a non-selective phosphodiesterase (PDE) inhibitor. Phosphodiesterases are enzymes responsible for breaking down cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) within cells. By inhibiting these enzymes, particularly PDE III and PDE IV, theophylline increases the intracellular concentration of cAMP. In the smooth muscles surrounding the bronchi (the main air passages to the lungs), elevated cAMP levels lead to muscle relaxation, effectively widening the airways and facilitating easier breathing.
Beyond simple bronchodilation, theophylline acts as a competitive antagonist at adenosine receptors (specifically A1 and A2 receptors). Adenosine is a signaling molecule that can cause bronchoconstriction (narrowing of the airways) in patients with asthma. By blocking these receptors, theophylline prevents adenosine-induced airway narrowing. Furthermore, recent clinical research suggests that low-dose theophylline may activate histone deacetylase 2 (HDAC2). HDAC2 is an enzyme that helps 'turn off' inflammatory genes; in patients with COPD and asthma, HDAC2 activity is often reduced, leading to steroid resistance. By restoring HDAC2 activity, theophylline may enhance the effectiveness of inhaled corticosteroids, though this is often achieved at lower serum concentrations than those required for bronchodilation.
Understanding the pharmacokinetics (how the body processes the drug) of Theophylline Anhydrous is critical because it has a narrow therapeutic index, meaning the difference between a safe dose and a toxic dose is small.
Theophylline Anhydrous is FDA-approved for the treatment of several chronic respiratory conditions. It is not intended for the treatment of acute bronchospasm (sudden asthma attacks) because its onset of action is too slow compared to 'rescue' inhalers like albuterol.
Theophylline Anhydrous is available in several delivery formats to suit different patient needs:
> Important: Only your healthcare provider can determine if Theophylline Anhydrous is right for your specific condition. Regular blood tests are required to ensure the dose is safe and effective.
Dosing for Theophylline Anhydrous is highly individualized and must be based on the patient's lean body weight, as the drug does not distribute well into body fat. Healthcare providers typically aim for a steady-state serum concentration of 5 to 15 mcg/mL.
Children metabolize theophylline much faster than adults, often requiring higher doses per kilogram of body weight.
While the kidneys only excrete 10% of unchanged theophylline, renal function can affect the clearance of metabolites. Dose adjustments are generally not required for mild-to-moderate renal impairment, but close monitoring is advised in severe cases or end-stage renal disease.
Because the liver is the primary site of metabolism, patients with cirrhosis, hepatitis, or liver congestion due to heart failure require significant dose reductions (often 50% or more). Failure to adjust the dose in these patients frequently leads to life-threatening toxicity.
Patients over the age of 65 often have reduced liver clearance and may have underlying heart conditions. Providers typically start at the lowest possible dose and titrate very slowly, aiming for the lower end of the therapeutic range (5-10 mcg/mL).
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Never double the dose to catch up, as this significantly increases the risk of toxicity.
Theophylline overdose is a medical emergency. Signs of toxicity include:
In the event of a suspected overdose, call 911 or your local emergency services immediately. Treatment in a hospital may involve activated charcoal, gastric lavage, or in severe cases, hemodialysis to remove the drug from the blood.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or switch brands without medical guidance, as different brands may not be bioequivalent.
Many patients experience mild side effects when starting Theophylline Anhydrous or when their dose is increased. These often diminish as the body adjusts to the medication. Common symptoms include:
> Warning: Stop taking Theophylline Anhydrous and call your doctor immediately or seek emergency care if you experience any of the following:
With prolonged use, theophylline is generally well-tolerated if levels are kept within the therapeutic range. However, long-term issues can include:
There are currently no FDA black box warnings for Theophylline Anhydrous. However, the FDA does require prominent warnings in the labeling regarding the narrow therapeutic index and the risk of severe toxicity (seizures and arrhythmias) at levels only slightly above the therapeutic range.
Report any unusual symptoms or changes in your health to your healthcare provider. Because theophylline interacts with many other conditions, a new symptom might indicate that your blood levels have changed unexpectedly.
The most critical safety aspect of Theophylline Anhydrous is its narrow therapeutic window. The difference between a dose that helps you breathe and a dose that causes a seizure is small. Therefore, regular blood monitoring (theophylline serum level tests) is mandatory. Patients must be aware that factors such as viral illnesses, changes in diet, or starting new medications can quickly push theophylline levels into the toxic range.
No FDA black box warnings for Theophylline Anhydrous. However, the 'Warnings' section of the official prescribing information emphasizes that serious toxicity (including fatalities) can occur without the presence of less serious prodromal symptoms (warning signs like nausea).
Theophylline can cause dizziness, restlessness, or tremors in some patients. Until you know how the medication affects you, use caution when driving or operating heavy machinery. If you experience significant 'jitters' or lightheadedness, consult your doctor.
Alcohol should be consumed with caution. Large amounts of alcohol can inhibit the liver enzymes that break down theophylline, potentially increasing the risk of side effects. Furthermore, alcohol can worsen the gastrointestinal side effects of the drug.
While theophylline does not typically cause a 'withdrawal syndrome' in the traditional sense, stopping it abruptly can lead to a rapid worsening of asthma or COPD symptoms (rebound bronchoconstriction). If the drug must be stopped, it is usually done under a doctor's supervision while another therapy is being started.
> Important: Discuss all your medical conditions, especially heart, liver, or kidney problems, with your healthcare provider before starting Theophylline Anhydrous.
Certain drugs should never be used with Theophylline Anhydrous because the risk of toxicity is unacceptably high:
Many drugs inhibit the CYP1A2 enzyme, which breaks down theophylline. Taking these can cause theophylline levels to skyrocket:
Conversely, some drugs 'induce' (speed up) the metabolism of theophylline, making it less effective:
Theophylline can interfere with certain medical tests, including:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those you only take occasionally.
There are specific scenarios where Theophylline Anhydrous must NEVER be used due to the risk of catastrophic health outcomes:
In these cases, a doctor will only prescribe theophylline if the benefits clearly outweigh the risks:
Patients who have experienced severe side effects or allergic reactions to other methylxanthines (such as Aminophylline or Oxtriphylline) or severe sensitivity to caffeine should be extremely cautious. While not a direct allergy, people who are 'caffeine-sensitive' (experiencing extreme anxiety or heart racing from one cup of coffee) are likely to experience similar, more intense effects from theophylline.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of heart, liver, or stomach issues, before prescribing Theophylline Anhydrous. Always disclose any previous adverse reactions to respiratory medications.
Theophylline Anhydrous is classified as FDA Pregnancy Category C. This means that animal studies have shown adverse effects on the fetus, but there are no adequate, well-controlled studies in humans. Theophylline crosses the placenta. While it has been used safely in many pregnant women, it should only be used if the potential benefit justifies the potential risk to the fetus.
Theophylline is excreted into breast milk and can reach concentrations similar to those in the mother's blood. About 1% to 10% of the mother's dose may reach the infant. Irritability, fretfulness, and insomnia have been reported in nursing infants whose mothers were taking theophylline. If breastfeeding is necessary, the mother should take the medication after a feeding to minimize the peak concentration the infant receives.
Theophylline is approved for use in children for asthma and chronic lung disease. However, it is used with caution due to the high variability in how children's bodies process the drug.
Adults over age 65 are at a significantly higher risk of theophylline toxicity.
In patients with end-stage renal disease (ESRD), the metabolites of theophylline (which have some pharmacological activity) can accumulate. While the parent drug is not primarily cleared by the kidneys, the overall clinical picture in renal failure requires careful monitoring. Hemodialysis effectively removes theophylline from the blood, so patients may need a supplemental dose after their dialysis session.
This is the most critical special population for theophylline. Patients with cirrhosis, acute hepatitis, or fatty liver disease have a drastically reduced ability to clear the drug. In some cases, the half-life can extend from 8 hours to over 50 hours. Dosing must be started very low (e.g., 100-200 mg/day) and increased only with frequent serum level monitoring.
> Important: Special populations require individualized medical assessment and more frequent laboratory monitoring than the general population.
Theophylline Anhydrous exerts its therapeutic effects through several molecular mechanisms. Its primary action is the non-selective inhibition of phosphodiesterase (PDE) enzymes, specifically PDE III and PDE IV. These enzymes are responsible for the hydrolysis of cyclic adenosine monophosphate (cAMP). By inhibiting PDE, theophylline increases intracellular cAMP levels in bronchial smooth muscle, leading to the activation of protein kinase A (PKA). PKA subsequently inhibits the phosphorylation of myosin light-chain kinase, resulting in smooth muscle relaxation and bronchodilation.
Additionally, theophylline acts as a competitive antagonist at adenosine A1 and A2 receptors. Adenosine is known to cause bronchoconstriction in asthmatic patients and can stimulate the release of histamine from mast cells. By blocking these receptors, theophylline provides an additional layer of protection against airway narrowing. At lower concentrations, theophylline also recruits histone deacetylase 2 (HDAC2) to the inflammatory gene complex, which helps suppress the expression of inflammatory cytokines, potentially reversing corticosteroid resistance in COPD patients.
The relationship between theophylline serum concentration and its effect is well-documented. Bronchodilation generally begins at levels around 5 mcg/mL, with maximum benefit typically seen between 10 and 20 mcg/mL. However, the risk of toxicity also increases significantly above 20 mcg/mL. The drug also increases the force of contraction of the diaphragm and increases the 'ventilatory drive' in the central nervous system, making it useful for patients with chronic respiratory failure.
| Parameter | Value |
|---|---|
| Bioavailability | 90% - 100% (Oral) |
| Protein Binding | ~40% (primarily Albumin) |
| Half-life | 7-9 hours (Healthy Adults); 3-4 hours (Smokers) |
| Tmax | 1-2 hours (IR); 4-10 hours (ER) |
| Metabolism | Hepatic (CYP1A2, CYP3A4) |
| Excretion | Renal (10% unchanged) |
Theophylline Anhydrous is a member of the Methylxanthine [EPC] class. Related medications include Aminophylline (a more soluble salt form) and Dyphylline (a derivative with different PK properties). It is therapeutically categorized as a bronchodilator and an anti-asthmatic agent.
Medications containing this ingredient
Common questions about Theophylline Anhydrous
Theophylline Anhydrous is primarily used for the long-term management of chronic respiratory diseases such as asthma, chronic bronchitis, and emphysema. It belongs to the methylxanthine class and works by relaxing the smooth muscles in the airways, which helps to open the lungs and make breathing easier. While it was once a first-line treatment, it is now typically used as an 'add-on' therapy when other inhalers like corticosteroids are not enough to control symptoms. It is also known to help strengthen the diaphragm, the main muscle used for breathing. It is important to note that this medication is not a rescue inhaler and should not be used for sudden asthma attacks.
The most common side effects of Theophylline Anhydrous are often related to its stimulant properties, which are similar to caffeine. Patients frequently report nausea, stomach upset, headaches, and insomnia, especially when first starting the medication or increasing the dose. You may also feel restless, nervous, or notice a slight tremor in your hands. Because the drug can increase stomach acid, some people experience heartburn or acid reflux. Most of these mild side effects tend to improve as your body gets used to the drug. However, if you experience persistent vomiting or a very rapid heartbeat, you should contact your healthcare provider immediately as these can be signs of toxicity.
You should exercise caution when consuming alcohol while taking Theophylline Anhydrous. Alcohol can interfere with the liver enzymes responsible for breaking down theophylline, which may lead to an unexpected increase in the drug's levels in your blood. This increase can raise your risk of experiencing dangerous side effects or toxicity. Additionally, both alcohol and theophylline can irritate the stomach lining, potentially worsening nausea or gastric reflux. It is generally best to limit alcohol intake and discuss your habits with your doctor. If you do choose to drink, do so in moderation and be alert for any signs of increased theophylline side effects.
Theophylline Anhydrous is considered a Pregnancy Category C medication, meaning its safety has not been fully established in human clinical trials. It is known to cross the placenta and enter the fetal circulation. Healthcare providers generally only prescribe it during pregnancy if the benefit of controlling the mother's asthma or COPD outweighs the potential risks to the developing baby. If you are taking theophylline and become pregnant, do not stop the medication abruptly, as uncontrolled asthma can also be dangerous for the fetus. Instead, consult your doctor immediately to discuss a management plan. Your doctor will likely need to monitor your blood levels more frequently, especially during the third trimester.
Theophylline Anhydrous is a slow-acting maintenance medication and does not provide immediate relief of breathing difficulties. When starting the oral extended-release tablets, it may take several days of consistent dosing to reach a 'steady state' where the drug level in your blood is constant and effective. Most patients begin to feel an improvement in their chronic symptoms within 3 to 7 days. Because of this slow onset, it is crucial to continue using your fast-acting rescue inhaler for any sudden shortness of breath. Your doctor will use blood tests to ensure the drug has reached the correct therapeutic level in your system. If you do not feel an improvement after two weeks, consult your healthcare provider.
You should not stop taking Theophylline Anhydrous suddenly without first consulting your healthcare provider. While the drug is not addictive, stopping it abruptly can cause a 'rebound' effect where your asthma or COPD symptoms significantly worsen in a short period. This can lead to severe shortness of breath or a respiratory flare-up that might require hospitalization. If your doctor decides that you no longer need theophylline, they will typically provide a schedule to gradually reduce your dose while starting a different medication. Always follow your provider's specific tapering instructions to ensure your airways remain stable during the transition.
If you miss a dose of Theophylline Anhydrous, take the missed dose as soon as you remember. However, if it is almost time for your next scheduled dose (within a few hours), you should skip the missed dose entirely and continue with your regular dosing schedule. It is vital that you never take two doses at once to make up for a missed one. Taking a double dose can easily push your blood levels into the toxic range, which can cause serious heart or neurological problems. If you find yourself frequently forgetting doses, consider using a pill organizer or setting a daily alarm on your phone. Consistent dosing is the only way to keep the drug working safely.
Weight gain is not a typical or common side effect of Theophylline Anhydrous. In fact, because the drug can cause nausea and a loss of appetite in some patients, it is more likely to cause slight weight loss if side effects are present. Theophylline is a metabolic stimulant, similar to caffeine, which can slightly increase the rate at which your body burns calories. If you notice significant or rapid weight gain while taking this medication, it may be due to other factors, such as the use of oral corticosteroids (like prednisone) which are often prescribed alongside theophylline for lung conditions. Always report unexpected weight changes to your doctor to determine the underlying cause.
Theophylline Anhydrous is notorious for having many drug interactions, some of which can be very dangerous. Many common medications, such as certain antibiotics (ciprofloxacin), heartburn drugs (cimetidine), and blood pressure medicines (propranolol), can change how your body processes theophylline. These interactions can either make theophylline reach toxic levels or make it completely ineffective. Because of this, it is essential to provide your doctor and pharmacist with a complete list of every medication, supplement, and herbal product you use. You should also check with your doctor before starting any new over-the-counter medicines. Regular blood monitoring is the best way to ensure that your other medications aren't interfering with your theophylline levels.
Yes, Theophylline Anhydrous is widely available as a generic medication in several different strengths and formulations. Generic versions are typically much less expensive than brand-name versions like Theo-24 or Elixophyllin. While generic medications are required by the FDA to have the same active ingredient and strength as the brand name, the way the 'extended-release' mechanism works can vary slightly between different manufacturers. Because theophylline has a narrow therapeutic index, some doctors prefer that patients stay on the same brand or the same generic manufacturer once a stable blood level is achieved. If your pharmacy changes your generic manufacturer, your doctor may want to check your blood levels again to be safe.